Online first
Short communication
Published online: 2024-06-13
Magnetically controlled capsule endoscopy in aging patients with cardiac implantable pacemakers: A retrospective pilot study
Pubmed: 38887782
Abstract
Not available
References
- Bhuva A, Charles-Edwards G, Ashmore J, et al. Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices. Heart. 2024; 110(4): e3.
- Tajstra M, Dyrbuś M, Wojtynek E, et al. Magnetic resonance imaging in patients with cardiac implantable electronic devices in the cardiooncology center. Kardiol Pol. 2023 [Epub ahead of print]; 81(6): 619–621.
- Jiang Xi, Pan J, Li ZS, et al. Standardized examination procedure of magnetically controlled capsule endoscopy. VideoGIE. 2019; 4(6): 239–243.
- Jiang B, Pan J, Qian YY, et al. Clinical guideline on magnetically controlled capsule gastroscopy (2021 edition). J Dig Dis. 2023; 24(2): 70–84.
- Nazarian S, Hansford R, Rahsepar A, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med. 2017; 377(26): 2555–2564.
- Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. 2013; 10(5): 685–691.
- Williamson BD, Gohn DC, Ramza BM, et al. Real-world evaluation of magnetic resonance imaging in patients with a magnetic resonance imaging conditional pacemaker system: Results of 4-year prospective follow-up in 2,629 patients. JACC Clin Electrophysiol. 2017; 3(11): 1231–1239.
- Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: In vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004; 110(5): 475–482.
- Yang E, Suzuki M, Nazarian S, et al. Magnetic resonance imaging safety in patients with cardiac implantable electronic devices. Trends Cardiovasc Med. 2022; 32(7): 440–447.
- Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med. 2017; 376(8): 755–764.
- Bhuva AN, Moralee R, Brunker T, et al. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices. Eur Heart J. 2022; 43(26): 2469–2478.
- Payeras G, Piqueras J, Moreno VJ, et al. Effects of capsule endoscopy on cardiac pacemakers. Endoscopy. 2005; 37(12): 1181–1185.
